P Trademark

Trademark Overview


On Wednesday, October 10, 2018, a trademark application was filed for P with the United States Patent and Trademark Office. The USPTO has given the P trademark a serial number of 79247239. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, March 12, 2026. This trademark is owned by Phebra Pty Ltd. The P trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain, cancer, infectious diseases, gastrointestinal diseases and conditions, skin conditions, respiratory conditions, neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, and human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, for the treatment of cancer, epilepsy and manic, depressive and psychotic states; medicinal preparations for the treatment of cancer, epilepsy and manic, depressive and psychotic states; vitamin preparations; electrolyte solutions for medical use, namely, electrolyte replacement solutions for medical use; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical use; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable solutions for medical purposes, namely, ste...
p

General Information


Serial Number79247239
Word MarkP
Filing DateWednesday, October 10, 2018
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, March 12, 2026
Registration Number5905778
Registration DateTuesday, November 12, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical preparations for the treatment of pain, cancer, infectious diseases, gastrointestinal diseases and conditions, skin conditions, respiratory conditions, neurological disorders, psychiatric disorders, genetic disorders, hormonal disorders, cardiovascular disorders, and human ion imbalances; cardiovascular agents for medical purposes; medicines for human purposes, namely, for the treatment of cancer, epilepsy and manic, depressive and psychotic states; medicinal preparations for the treatment of cancer, epilepsy and manic, depressive and psychotic states; vitamin preparations; electrolyte solutions for medical use, namely, electrolyte replacement solutions for medical use; vaccines; antidotes; diagnostic agents for pharmaceutical use; diagnostic preparations for medical use; in-vivo diagnostic agents used to visualize and differentiate tissues in the body, or to monitor the functioning and patency of tissues and organs; injectable solutions for medical purposes, namely, sterile injectable dyes for in vivo human medical diagnostic procedures
Description of MarkThe mark consists of a stylized letter "P" inside of a circle.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 14, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePhebra Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type81 - NOT AVAILABLE
AddressGB

Party NamePhebra Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type81 - NOT AVAILABLE
AddressGB

Party NamePhebra Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type81 - NOT AVAILABLE
AddressGB

Trademark Events


Event DateEvent Description
Thursday, December 13, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, December 14, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 18, 2018APPLICATION FILING RECEIPT MAILED
Saturday, January 19, 2019ASSIGNED TO EXAMINER
Wednesday, January 23, 2019NON-FINAL ACTION WRITTEN
Thursday, January 24, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, February 4, 2019REFUSAL PROCESSED BY MPU
Monday, February 4, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, February 22, 2019REFUSAL PROCESSED BY IB
Wednesday, June 26, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 1, 2019ASSIGNED TO LIE
Wednesday, July 3, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 23, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 7, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 7, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 23, 2019NOTIFICATION PROCESSED BY IB
Tuesday, August 27, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, February 12, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 6, 2020FINAL DISPOSITION PROCESSED
Friday, March 6, 2020FINAL DISPOSITION NOTICE SENT TO IB
Friday, March 27, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 30, 2020NEW REPRESENTATIVE AT IB RECEIVED
Monday, March 14, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, March 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 14, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, March 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 14, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 12, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, November 13, 2025TEAS SECTION 71 & 15 RECEIVED
Monday, March 9, 2026CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 12, 2026REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, March 12, 2026NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED